Stephen Ettinghausen

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

New England Journal of Medicine · 1985 · 2,521 citations

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2

The Journal of Immunology · 1985 · 668 citations